Apolipoprotein E and presenilin-1 genotypes in Huntington's disease

J Neurol. 1999 Jul;246(7):574-7. doi: 10.1007/s004150050406.

Abstract

Huntington's disease (HD) is an autosomal dominant degenerative disease of the central nervous system manifested by involuntary movements (chorea), psychiatric manifestations, and cognitive impairment with a variable age at onset. This variability is mainly attributed to genetic factors. The so-called aging genes [e.g., those for apolipoprotein E (APOE) and presenilin-1 (PS-1) have been implicated in determining the age at onset of Alzheimer's disease, a disease sharing common clinical features with HD. In 60 unrelated patients suffering from HD (mean age at onset 40.1 years, range 20-65) we determined number of CAG repeats and the distribution of the APOE alleles (epsilon2, epsilon3, epsilon4) and PS-1 alleles. The results showed that: (a) The age at onset was higher in the group of patients with the epsilon4 allele (51.6 vs. 38.0 P<0.002), (b) The correlation between the age at onset and the number of CAG repeats was strong in patients with the epsilon3/epsilon3 genotype while it was not detected in patients with epsilon3/epsilon4 genotype. (c) No correlation was found between age at onset and PS-1 alleles. In conclusion, APOE seems to be a significant factor influencing the age at onset of Huntington's disease.

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Apolipoproteins E / genetics*
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Huntington Disease / genetics*
  • Huntington Disease / physiopathology
  • Male
  • Membrane Proteins / genetics*
  • Middle Aged
  • Presenilin-1
  • Trinucleotide Repeats

Substances

  • Apolipoproteins E
  • Membrane Proteins
  • PSEN1 protein, human
  • Presenilin-1